VIDEO: Determining individual risk for ovarian cancer in primary care settings

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

There are a number of indications that we really need sort of the primary care community to be aware of. The first is that all patients who are diagnosed with ovarian cancer should get genetic testing. Sadly, that's not happening at the rate and frequency that is recommended. That's super important because we just talked about how if you have ovarian cancer and you have a BRCA mutation or a tumor that looks like it might, you might be susceptible, and might be able to benefit from PARP inhibitors. And so knowing your status is important. It also has implications for the family, and genetic counseling, and being able to tell your loved ones, first-degree relatives and so on, that you might have this mutation in the family and they should get tested. So there are a lot of implications, not just for the patient themselves, but for their family. So I think that's super important to try to understand that. I would say that if you have ovarian cancer, and you get tested, and there's a positive result, meaning that you have a mutation in the BRCA genes, genetic counseling is highly advised to help walk through all those decision processes that you have to consider. So I think, you know, being at a place where you can get good genetic counseling is also important.